Quantrx Biomedical Valuation
| QTXBDelisted Stock | USD 0.0005 0.00 0.00% |
Quantrx Biomedical seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Quantrx Biomedical from analyzing the company fundamentals such as Shares Owned By Insiders of 18.74 %, return on asset of -2.1, and EBITDA of (43.38 K) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Quantrx Biomedical's price fluctuation is very steady at this time. Calculation of the real value of Quantrx Biomedical is based on 3 months time horizon. Increasing Quantrx Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Quantrx Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Quantrx Pink Sheet. However, Quantrx Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.0E-4 | Real 4.25E-4 | Hype 5.0E-4 | Naive 5.0E-4 |
The real value of Quantrx Pink Sheet, also known as its intrinsic value, is the underlying worth of Quantrx Biomedical Company, which is reflected in its stock price. It is based on Quantrx Biomedical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Quantrx Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Quantrx Biomedical helps investors to forecast how Quantrx pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Quantrx Biomedical more accurately as focusing exclusively on Quantrx Biomedical's fundamentals will not take into account other important factors: About Quantrx Biomedical Valuation
The pink sheet valuation mechanism determines Quantrx Biomedical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Quantrx Biomedical. We calculate exposure to Quantrx Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Quantrx Biomedical's related companies.QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads and PAD based over-the-counter products in the United States. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon. Quantrx Biomedical is traded on OTC Exchange in the United States.
8 Steps to conduct Quantrx Biomedical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Quantrx Biomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Quantrx Biomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Quantrx Biomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Quantrx Biomedical's revenue streams: Identify Quantrx Biomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Quantrx Biomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Quantrx Biomedical's growth potential: Evaluate Quantrx Biomedical's management, business model, and growth potential.
- Determine Quantrx Biomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Quantrx Biomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Quantrx Biomedical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 78.7 M | |
| Retained Earnings | -52.4 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Quantrx Pink Sheet
If you are still planning to invest in Quantrx Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Quantrx Biomedical's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |